In conclusion, it were found that: 1) downregulated MT1M in HCC tumors was a potential tumor marker; 2) MT1M suppressed HCC tumorigenesis possibly by inducing cell cycle arrest, enhancing apoptosis and inhibiting cell migration and invasion. This evidence concerns the gene MT1M and hepatocellular carcinoma.